A.R.T. Advisors, LLC - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 99 filers reported holding INTERSECT ENT INC in Q2 2016. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q4 2019$647,000
+20.0%
25,977
+9.7%
0.03%
+3.2%
Q2 2019$539,000
+1.5%
23,677
+25.5%
0.03%
-8.8%
Q4 2018$531,000
-58.9%
18,860
-58.1%
0.03%
-42.4%
Q3 2018$1,292,000
+27.0%
44,963
+65.5%
0.06%
+43.9%
Q2 2018$1,017,000
+27.9%
27,163
+34.2%
0.04%
+28.1%
Q1 2018$795,000
-42.8%
20,242
-52.9%
0.03%
-48.4%
Q4 2017$1,391,000
-41.9%
42,942
-44.1%
0.06%
-49.2%
Q3 2017$2,393,000
+145.7%
76,842
+120.4%
0.12%
+134.6%
Q2 2017$974,000
+274.6%
34,864
+129.4%
0.05%
+333.3%
Q1 2017$260,000
-26.3%
15,200
-47.9%
0.01%
-42.9%
Q4 2016$353,000
+57.6%
29,200
+68.1%
0.02%
+90.9%
Q2 2016$224,000
-53.1%
17,372
-31.0%
0.01%
-47.6%
Q1 2016$478,000
+30.6%
25,172
+60.8%
0.02%
+50.0%
Q3 2015$366,000
-32.6%
15,659
-17.5%
0.01%
-22.2%
Q2 2015$543,00018,9900.02%
Other shareholders
INTERSECT ENT INC shareholders Q2 2016
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 186,561$5,364,0004.51%
First Light Asset Management, LLC 517,121$14,867,0002.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,147,950$61,754,0002.21%
HealthCor Management, L.P. 1,950,000$56,063,0001.86%
PURA VIDA INVESTMENTS, LLC 200,000$5,750,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 112,000$2,469,0001.17%
Broadfin Capital, LLC 234,200$6,733,0000.99%
Lombard Odier Asset Management (USA) Corp 240,000$6,900,0000.51%
PURA VIDA INVESTMENTS, LLC 83,527$2,401,0000.50%
Rock Springs Capital Management LP 460,000$13,225,0000.48%
View complete list of INTERSECT ENT INC shareholders